Genetics Clinical Trials This is an OPML file. It can be used to export all the MedWorm RSS feeds on this topic into your personal RSS reader (usually you have to save this file to your own computer before clicking on an Import OPML command in your own feed reader to upload the file which will then import all the feeds) or it can be used by webmasters to integrate MedWorm feeds with their own website. This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. Subscribe to this data using MyMedWorm.Subscribe to this data using GoogleReader.Subscribe to this data using Bloglines.Subscribe to this data using MyYahoo.

This page shows you the most recent publications within this specialty of the MedWorm directory.

Prevention of Ovarian Cancer in Women Participating in Mammography
Condition: Epithelial Ovarian CancerIntervention: Behavioral: genetic counselingSponsors: Fred Hutchinson Cancer Research Center; Fred Hutchinson Cancer Research Center; Swedish Medical CenterActive, not recruiting - verified May 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 3, 2013 Category: Research Source Type: clinical trials

Agios to Present IDH Program Insights at Tumor Metabolism Keystone Symposia
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb 22, 2013 - Agios Pharmaceuticals, Inc., the leading biopharmaceutical company focused on discovering and developing novel drugs in the fields of cancer metabolism and rare metabolic genetic diseases,... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - February 22, 2013 Category: Pharmaceuticals Source Type: clinical trials

A Randomized Study of Radiation Hypofractionation Via Extended Versus Accelerated Therapy (HEAT) For Prostate Cancer
Condition: Prostate CancerInterventions: Radiation: Extended Hypofractionation Radiotherapy; Radiation: Accelerated Hypofractionation Radiotherapy; Procedure: Fiducial Marker Placement; Behavioral: Quality of Life Questionnaires; Procedure: Prostate Biopsy; Genetic: Biopsy Tissue for Biomarkers; Genetic: Biofluids for proteomics and genomics studiesSponsors: University of Miami Sylvester Comprehensive Cancer Center; University of Miami Sylvester Comprehensive Cancer CenterNot yet recruiting - verified February 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 14, 2013 Category: Research Source Type: clinical trials

Radiation Hypofractionation Via Extended Versus Accelerated Therapy (HEAT) For Prostate Cancer
Condition: Prostate CancerInterventions: Radiation: Extended Hypofractionation Radiotherapy; Radiation: Accelerated Hypofractionation Radiotherapy; Procedure: Fiducial Marker Placement; Behavioral: Quality of Life Questionnaires; Procedure: Prostate Biopsy; Genetic: Biopsy Tissue for Biomarkers; Genetic: Biofluids for proteomics and genomics studiesSponsors: University of Miami Sylvester Comprehensive Cancer Center; University of Miami Sylvester Comprehensive Cancer CenterNot yet recruiting - verified February 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 14, 2013 Category: Research Source Type: clinical trials

Radiation Hypofractionation Via Extended Versus Accelerated Therapy (HEAT) For Prostate Cancer
Condition: Prostate CancerInterventions: Radiation: Extended Hypofractionation Radiotherapy; Radiation: Accelerated Hypofractionation Radiotherapy; Procedure: Fiducial Marker Placement; Behavioral: Quality of Life Questionnaires; Procedure: Prostate Biopsy; Genetic: Biopsy Tissue for Biomarkers; Genetic: Biofluids for proteomics and genomics studiesSponsors: University of Miami Sylvester Comprehensive Cancer Center; University of Miami Sylvester Comprehensive Cancer CenterRecruiting - verified March 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 14, 2013 Category: Research Source Type: clinical trials

New Research Project for recurrent glioblastoma patients on Avastin - Get a free genetic analysis!
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - January 29, 2013 Category: Cancer & Oncology Source Type: clinical trials

Intracerebral Gene Therapy for Children With Early Onset Forms of Metachromatic Leukodystrophy
Condition: Metachromatic LeukodystrophyIntervention: Genetic: intracerebral administration of AAVrh.10cuARSASponsors: Institut National de la Santé Et de la Recherche Médicale, France; Institut National de la Santé Et de la Recherche Médicale, France; European Leukodystrophy Association; Assistance Publique - Hôpitaux de ParisRecruiting - verified March 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 28, 2013 Category: Research Source Type: clinical trials

Seattle Genetics Announces Data from ASG-5ME Phase I Clinical Trial for Pancreatic Cancer
- ASG-5ME is a Novel Antibody-Drug Conjugate in Evaluation for the Treatment of Pancreatic, Gastric and Prostate Cancers - BOTHELL, Wash.--(BUSINESS WIRE)--Jan 25, 2013 - Seattle Genetics, Inc. (Nasdaq: SGEN) today presented interim results from a... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - January 25, 2013 Category: Pharmaceuticals Source Type: clinical trials

Limb Girdle Muscular Dystrophy (LGMD) Natural History
Condition: Muscular Dystrophies, Limb-Girdle (GENETICALLY CONFIRMED)Intervention: Sponsors: Carolinas Healthcare System; Susan Sparks; Muscular Dystrophy AssociationRecruiting - verified February 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 18, 2013 Category: Research Source Type: clinical trials

Program to Establish the Genetic and Immunologic Profile of Patient's Tumor for All Types of Advanced Cancer
Condition: NeoplasmsIntervention: Genetic: Blood and tumor samplesSponsors: Centre Leon Berard; Centre Leon BerardNot yet recruiting - verified January 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2013 Category: Research Source Type: clinical trials

Genetically Modified Peripheral Blood Stem Cell Transplant in Treating Patients With HIV-Associated Non-Hodgkin or Hodgkin Lymphoma
Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma; AIDS-related Diffuse Large Cell Lymphoma; AIDS-related Diffuse Mixed Cell Lymphoma; AIDS-related Diffuse Small Cleaved Cell Lymphoma; AIDS-related Immunoblastic Large Cell Lymphoma; AIDS-related Lymphoblastic Lymphoma; AIDS-related Peripheral/Systemic Lymphoma; AIDS-related Small Noncleaved Cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Cutaneous B-cell Non-Hodgkin Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; ...
Source: ClinicalTrials.gov - January 15, 2013 Category: Research Source Type: clinical trials

Genetic Form of Anemia Offers New Avenue to Treating Drug-resistant Tumors
Sickle-shaped red blood cells target and destroy tumor cells and blood vessels CARMEL, Calif., Jan. 9, 2013 /PRNewswire/ -- The genetic mutation that causes sickle cell anemia also turns red blood cells into potent tumor killers and may offer... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - January 10, 2013 Category: Pharmaceuticals Source Type: clinical trials

Gencaro Effect on Reducing Ventricular Arrhythmias Paper Published in Circulation: Arrhythmia and Electrophysiology
BROOMFIELD, Colo.--(BUSINESS WIRE)--Jan 3, 2013 - ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company developing genetically-targeted therapies for atrial fibrillation and other cardiovascular diseases, today announced that the... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - January 3, 2013 Category: Pharmaceuticals Source Type: clinical trials

Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation.
Conditions: Alzheimers Disease; Dementia; Alzheimers Disease, FamilialInterventions: Drug: Gantenerumab; Drug: Solanezumab; Drug: Matching Placebo (Gantenerumab); Drug: Matching Placebo (Solanezumab)Sponsors: Washington University School of Medicine; Washington University School of Medicine; Eli Lilly and Company; Hoffmann-La Roche; Alzheimer's AssociationNot yet recruiting - verified December 2012 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 26, 2012 Category: Research Source Type: clinical trials

Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation.
Conditions: Alzheimers Disease; Dementia; Alzheimers Disease, FamilialInterventions: Drug: Gantenerumab; Drug: Solanezumab; Drug: Matching Placebo (Gantenerumab); Drug: Matching Placebo (Solanezumab)Sponsors: Washington University School of Medicine; Washington University School of Medicine; Eli Lilly and Company; Hoffmann-La Roche; Alzheimer's AssociationRecruiting - verified January 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 26, 2012 Category: Research Source Type: clinical trials